• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析分化型人类诱导多能干细胞和人类胚胎干细胞的致癌性和肿瘤生成潜能。

Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells.

机构信息

Departments of Medicine, Stanford University School of Medicine, Stanford, CA 94305-5454, USA.

出版信息

Cancer Res. 2011 Jul 15;71(14):5030-9. doi: 10.1158/0008-5472.CAN-10-4402. Epub 2011 Jun 6.

DOI:10.1158/0008-5472.CAN-10-4402
PMID:21646469
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3138859/
Abstract

Pluripotent stem cells, both human embryonic stem cells (hESC) and human-induced pluripotent stem cells (hiPSC), can give rise to multiple cell types and hence have tremendous potential for regenerative therapies. However, the tumorigenic potential of these cells remains a great concern, as reflected in the formation of teratomas by transplanted pluripotent cells. In clinical practice, most pluripotent cells will be differentiated into useful therapeutic cell types such as neuronal, cardiac, or endothelial cells prior to human transplantation, drastically reducing their tumorigenic potential. Our work investigated the extent to which these differentiated stem cell derivatives are truly devoid of oncogenic potential. In this study, we analyzed the gene expression patterns from three sets of hiPSC- and hESC-derivatives and the corresponding primary cells, and compared their transcriptomes with those of five different types of cancer. Our analysis revealed a significant gene expression overlap of the hiPSC- and hESC-derivatives with cancer, whereas the corresponding primary cells showed minimum overlap. Real-time quantitative PCR analysis of a set of cancer-related genes (selected on the basis of rigorous functional and pathway analyses) confirmed our results. Overall, our findings suggested that pluripotent stem cell derivatives may still bear oncogenic properties even after differentiation, and additional stringent functional assays to purify these cells should be done before they can be used for regenerative therapy.

摘要

多能干细胞,包括人类胚胎干细胞(hESC)和人类诱导多能干细胞(hiPSC),可以分化为多种细胞类型,因此在再生疗法方面具有巨大的潜力。然而,这些细胞的致瘤潜能仍然是一个很大的关注点,因为移植的多能细胞会形成畸胎瘤。在临床实践中,大多数多能细胞在移植到人体之前会被分化为有用的治疗性细胞类型,如神经元、心脏或内皮细胞,这极大地降低了它们的致瘤潜能。我们的工作研究了这些分化后的干细胞衍生物在多大程度上真正没有致癌潜能。在这项研究中,我们分析了三组 hiPSC 和 hESC 衍生物及其相应的原代细胞的基因表达模式,并将它们的转录组与五种不同类型的癌症进行了比较。我们的分析表明,hiPSC 和 hESC 衍生物与癌症的基因表达有显著的重叠,而相应的原代细胞的重叠最小。基于严格的功能和途径分析,对一组与癌症相关的基因(基于功能和途径分析选择)进行实时定量 PCR 分析,进一步证实了我们的结果。总的来说,我们的研究结果表明,多能干细胞衍生物即使在分化后仍可能具有致癌特性,在将其用于再生治疗之前,应该进行额外的严格的功能检测来纯化这些细胞。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/ac6032f66bdb/nihms-300360-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/46b319563ab0/nihms-300360-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/470397f3f4d0/nihms-300360-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/69d13137b116/nihms-300360-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/fff16cba381e/nihms-300360-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/90f674533882/nihms-300360-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/e7f6c01006c1/nihms-300360-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/ac6032f66bdb/nihms-300360-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/46b319563ab0/nihms-300360-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/470397f3f4d0/nihms-300360-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/69d13137b116/nihms-300360-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/fff16cba381e/nihms-300360-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/90f674533882/nihms-300360-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/e7f6c01006c1/nihms-300360-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/89e6/3138859/ac6032f66bdb/nihms-300360-f0007.jpg

相似文献

1
Dissecting the oncogenic and tumorigenic potential of differentiated human induced pluripotent stem cells and human embryonic stem cells.解析分化型人类诱导多能干细胞和人类胚胎干细胞的致癌性和肿瘤生成潜能。
Cancer Res. 2011 Jul 15;71(14):5030-9. doi: 10.1158/0008-5472.CAN-10-4402. Epub 2011 Jun 6.
2
Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.人诱导多能干细胞和胚胎干细胞来源的内皮细胞的功能特征和表达谱分析。
Stem Cells Dev. 2011 Oct;20(10):1701-10. doi: 10.1089/scd.2010.0426. Epub 2011 Feb 28.
3
Genetic and epigenetic stability of human pluripotent stem cells.人类多能干细胞的遗传和表观遗传稳定性。
Nat Rev Genet. 2012 Oct;13(10):732-44. doi: 10.1038/nrg3271. Epub 2012 Sep 11.
4
miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells.miR-371-3 的表达可预测人多能干细胞的神经分化倾向。
Cell Stem Cell. 2011 Jun 3;8(6):695-706. doi: 10.1016/j.stem.2011.04.002.
5
Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.源自诱导多能干细胞畸胎瘤的人类细胞的可逆转化和去分化。
Hum Cell. 2016 Jan;29(1):1-9. doi: 10.1007/s13577-015-0119-1. Epub 2015 Jun 12.
6
Comparative analysis of targeted differentiation of human induced pluripotent stem cells (hiPSCs) and human embryonic stem cells reveals variability associated with incomplete transgene silencing in retrovirally derived hiPSC lines.比较分析人诱导多能干细胞(hiPSCs)和人胚胎干细胞的靶向分化,揭示了与逆转录病毒衍生的 hiPSC 系中不完全基因沉默相关的可变性。
Stem Cells Transl Med. 2013 Feb;2(2):83-93. doi: 10.5966/sctm.2012-0047. Epub 2013 Jan 22.
7
Markers of pluripotency and differentiation in human neural precursor cells derived from embryonic stem cells and CNS tissue.胚胎干细胞和中枢神经系统组织来源的人神经前体细胞中的多能性和分化标志物。
Cell Transplant. 2011;20(2):177-91. doi: 10.3727/096368910X527266. Epub 2010 Sep 27.
8
Aquaporin expression and function in human pluripotent stem cell-derived retinal pigmented epithelial cells.水通道蛋白在人多能干细胞源性视网膜色素上皮细胞中的表达和功能。
Invest Ophthalmol Vis Sci. 2013 May 1;54(5):3510-9. doi: 10.1167/iovs.13-11800.
9
Intrinsic properties and external factors determine the differentiation bias of human embryonic stem cell lines.内在特性和外部因素决定了人类胚胎干细胞系的分化偏向。
Cell Biol Int. 2010 Oct;34(10):1021-31. doi: 10.1042/CBI20100283.
10
Teratoma: from spontaneous tumors to the pluripotency/malignancy assay.畸胎瘤:从自发肿瘤到多能性/恶性测定
Wiley Interdiscip Rev Dev Biol. 2016 Mar-Apr;5(2):186-209. doi: 10.1002/wdev.219. Epub 2015 Dec 23.

引用本文的文献

1
Claudin-6 mediates an embryonic stem cell-driven antitumor response against breast cancer.Claudin-6介导胚胎干细胞驱动的抗乳腺癌抗肿瘤反应。
iScience. 2025 May 16;28(6):112688. doi: 10.1016/j.isci.2025.112688. eCollection 2025 Jun 20.
2
Footprint-free induced pluripotent stem cells can be successfully differentiated into mesenchymal stromal cells in the feline model.在猫科动物模型中,无足迹诱导多能干细胞可成功分化为间充质基质细胞。
Stem Cell Res Ther. 2025 Apr 20;16(1):195. doi: 10.1186/s13287-025-04325-2.
3
Evaluation of the safety and efficiency of cytotoxic T cell therapy sensitized by tumor antigens original from T-ALL-iPSC in vivo.评估源自T-ALL-iPSC的肿瘤抗原致敏的细胞毒性T细胞疗法在体内的安全性和有效性。
Cancer Innov. 2023 Oct 19;3(1):e95. doi: 10.1002/cai2.95. eCollection 2024 Feb.
4
Neoantigen-augmented iPSC cancer vaccine combined with radiotherapy promotes antitumor immunity in poorly immunogenic cancers.新抗原增强的诱导多能干细胞癌症疫苗联合放疗可促进低免疫原性癌症中的抗肿瘤免疫。
NPJ Vaccines. 2024 May 31;9(1):95. doi: 10.1038/s41541-024-00881-5.
5
Endoplasmic reticulum stress-induced senescence in human lung fibroblasts.内质网应激诱导的人肺成纤维细胞衰老。
Am J Physiol Lung Cell Mol Physiol. 2024 Jul 1;327(1):L126-L139. doi: 10.1152/ajplung.00264.2023. Epub 2024 May 21.
6
Immunization with Embryonic Stem Cells/Induced Pluripotent Stem Cells Induces Effective Immunity against Ovarian Tumor-Initiating Cells in Mice.用胚胎干细胞/诱导多能干细胞进行免疫可诱导小鼠对卵巢肿瘤起始细胞产生有效免疫。
Stem Cells Int. 2023 Nov 3;2023:8188324. doi: 10.1155/2023/8188324. eCollection 2023.
7
Application of Induced Pluripotent Stem Cells in Malignant Solid Tumors.诱导多能干细胞在恶性实体肿瘤中的应用。
Stem Cell Rev Rep. 2023 Nov;19(8):2557-2575. doi: 10.1007/s12015-023-10633-y. Epub 2023 Sep 27.
8
Induced Pluripotent Stem Cell-Derived Corneal Cells: Current Status and Application.诱导多能干细胞衍生的角膜细胞:现状与应用。
Stem Cell Rev Rep. 2022 Dec;18(8):2817-2832. doi: 10.1007/s12015-022-10435-8. Epub 2022 Aug 1.
9
The Potential of Induced Pluripotent Stem Cells to Advance the Treatment of Pancreatic Ductal Adenocarcinoma.诱导多能干细胞推动胰腺导管腺癌治疗的潜力
Cancers (Basel). 2021 Nov 18;13(22):5789. doi: 10.3390/cancers13225789.
10
Cell Fate Reprogramming in the Era of Cancer Immunotherapy.癌症免疫治疗时代的细胞命运重编程。
Front Immunol. 2021 Jul 21;12:714822. doi: 10.3389/fimmu.2021.714822. eCollection 2021.

本文引用的文献

1
Highly efficient miRNA-mediated reprogramming of mouse and human somatic cells to pluripotency.高效 miRNA 介导的小鼠和人体细胞重编程为多能性。
Cell Stem Cell. 2011 Apr 8;8(4):376-88. doi: 10.1016/j.stem.2011.03.001.
2
Single cell transcriptional profiling reveals heterogeneity of human induced pluripotent stem cells.单细胞转录组谱分析揭示了人类诱导多能干细胞的异质性。
J Clin Invest. 2011 Mar;121(3):1217-21. doi: 10.1172/JCI44635. Epub 2011 Feb 7.
3
Functional characterization and expression profiling of human induced pluripotent stem cell- and embryonic stem cell-derived endothelial cells.人诱导多能干细胞和胚胎干细胞来源的内皮细胞的功能特征和表达谱分析。
Stem Cells Dev. 2011 Oct;20(10):1701-10. doi: 10.1089/scd.2010.0426. Epub 2011 Feb 28.
4
Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA.利用合成修饰 mRNA 高效重编程人类细胞为多能性干细胞并进行定向分化。
Cell Stem Cell. 2010 Nov 5;7(5):618-30. doi: 10.1016/j.stem.2010.08.012. Epub 2010 Sep 30.
5
Glycogene expression alterations associated with pancreatic cancer epithelial-mesenchymal transition in complementary model systems.与胰腺癌上皮-间充质转化相关的糖基因表达改变在互补模型系统中的研究。
PLoS One. 2010 Sep 27;5(9):e13002. doi: 10.1371/journal.pone.0013002.
6
Promotion of direct reprogramming by transformation-deficient Myc.通过转化缺陷 Myc 促进直接重编程。
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14152-7. doi: 10.1073/pnas.1009374107. Epub 2010 Jul 26.
7
A teratocarcinoma-like human embryonic stem cell (hESC) line and four hESC lines reveal potentially oncogenic genomic changes.一个畸胎瘤样的人胚胎干细胞(hESC)系和四个 hESC 系揭示了潜在的致癌基因组变化。
PLoS One. 2010 Apr 23;5(4):e10263. doi: 10.1371/journal.pone.0010263.
8
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity.人类胚胎干细胞系的高分辨率 DNA 分析揭示了培养诱导的拷贝数变化和杂合性丢失。
Nat Biotechnol. 2010 Apr;28(4):371-7. doi: 10.1038/nbt.1615. Epub 2010 Mar 28.
9
A comparison of whole genome gene expression profiles of HepaRG cells and HepG2 cells to primary human hepatocytes and human liver tissues.将 HepaRG 细胞和 HepG2 细胞与原代人肝细胞和人肝组织的全基因组基因表达谱进行比较。
Drug Metab Dispos. 2010 Jun;38(6):988-94. doi: 10.1124/dmd.109.031831. Epub 2010 Mar 12.
10
A nonviral minicircle vector for deriving human iPS cells.一种用于诱导人多能干细胞的非病毒微小环载体。
Nat Methods. 2010 Mar;7(3):197-9. doi: 10.1038/nmeth.1426. Epub 2010 Feb 7.